1st Quarter - Report

BOCKORNY GROUP, INC. for CVS HEALTH INC

Period 1st Quarter 2021 Filed Apr 19, 2021 Signed by David Bockorny

Official filing
Firm
BOCKORNY GROUP, INC.
Client
CVS HEALTH INC
Income
$80,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Issues related to PBMs Issues related to drug pricing Issues related to Veterans health Issues related to opioid abuse Issues related to health reform proposals Issues related to the "Gag Rule" bill Issues related to dialysis reimbursements Issues related to representation in COVID-19-related packages H.R. 133 Consolidated Appropriations Act, 2021

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
RAPHAEL GOODSTEIN New Legislative Correspondent, Senator Debbie Stabenow (2002-2004)
BLAIR C LARKINS —
JOSEPH RUBIN —
SCOTT STYLES —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; White House Office

Bills named: H.R. 133 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.